These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
480 related articles for article (PubMed ID: 29784057)
1. Incidence of hypotension according to the discontinuation order of vasopressors in the management of septic shock: a prospective randomized trial (DOVSS). Jeon K; Song JU; Chung CR; Yang JH; Suh GY Crit Care; 2018 May; 22(1):131. PubMed ID: 29784057 [TBL] [Abstract][Full Text] [Related]
2. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock. Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496 [TBL] [Abstract][Full Text] [Related]
3. Evaluating Vasopressor Discontinuation Strategies in Patients With Septic Shock on Concomitant Norepinephrine and Vasopressin Infusions. Musallam N; Altshuler D; Merchan C; Zakhary B; Aberle C; Papadopoulos J Ann Pharmacother; 2018 Aug; 52(8):733-739. PubMed ID: 29560736 [TBL] [Abstract][Full Text] [Related]
4. Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis. Song JU; Lee J; Park HK; Suh GY; Jeon K J Korean Med Sci; 2020 Jan; 35(1):e8. PubMed ID: 31898435 [TBL] [Abstract][Full Text] [Related]
5. Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: a retrospective cohort study. Bauer SR; Aloi JJ; Ahrens CL; Yeh JY; Culver DA; Reddy AJ J Crit Care; 2010 Jun; 25(2):362.e7-362.e11. PubMed ID: 19926252 [TBL] [Abstract][Full Text] [Related]
6. Norepinephrine vs Vasopressin: Which Vasopressor Should Be Discontinued First in Septic Shock? A Meta-Analysis. Wu Z; Zhang S; Xu J; Xie J; Huang L; Huang Y; Yang Y; Qiu H Shock; 2020 Jan; 53(1):50-57. PubMed ID: 31008869 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock. Wu JY; Stollings JL; Wheeler AP; Semler MW; Rice TW Ann Pharmacother; 2017 Jan; 51(1):13-20. PubMed ID: 27630192 [TBL] [Abstract][Full Text] [Related]
8. Vasopressor Discontinuation Order in Septic Shock With Reduced Left Ventricular Function. Taylor A; Jones T; Forehand CC; Smith SE; Dykes H; Newsome AS J Pharm Pract; 2022 Dec; 35(6):879-885. PubMed ID: 33977793 [TBL] [Abstract][Full Text] [Related]
9. Selepressin, a novel selective vasopressin V Russell JA; Vincent JL; Kjølbye AL; Olsson H; Blemings A; Spapen H; Carl P; Laterre PF; Grundemar L Crit Care; 2017 Aug; 21(1):213. PubMed ID: 28807037 [TBL] [Abstract][Full Text] [Related]
10. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database. He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890 [TBL] [Abstract][Full Text] [Related]
11. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Lauzier F; Lévy B; Lamarre P; Lesur O Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548 [TBL] [Abstract][Full Text] [Related]
12. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension. Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354 [TBL] [Abstract][Full Text] [Related]
13. Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock. Hammond DA; McCain K; Painter JT; Clem OA; Cullen J; Brotherton AL; Chopra D; Meena N J Intensive Care Med; 2019 Oct; 34(10):805-810. PubMed ID: 28618919 [TBL] [Abstract][Full Text] [Related]
14. Incidence of Hypotension Associated With Two Different Vasopressin Discontinuation Strategies in the Recovery Phase of Septic Shock. Murata J; Buckley M; Lehn J; Agarwal SK; Stevenson B; Martinez B; MacLaren R J Pharm Pract; 2023 Aug; 36(4):830-838. PubMed ID: 35331049 [No Abstract] [Full Text] [Related]
15. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial. Gordon AC; Mason AJ; Thirunavukkarasu N; Perkins GD; Cecconi M; Cepkova M; Pogson DG; Aya HD; Anjum A; Frazier GJ; Santhakumaran S; Ashby D; Brett SJ; JAMA; 2016 Aug; 316(5):509-18. PubMed ID: 27483065 [TBL] [Abstract][Full Text] [Related]
17. Effects of the discontinuation sequence of norepinephrine and vasopressin on hypotension incidence in patients with septic shock: A meta-analysis. Duclos G; Baumstarck K; Dünser M; Zieleskiewicz L; Leone M Heart Lung; 2019; 48(6):560-565. PubMed ID: 31126701 [TBL] [Abstract][Full Text] [Related]
18. Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock. Lam SW; Sacha GL; Duggal A; Reddy AJ; Bauer SR Shock; 2021 Feb; 55(2):210-214. PubMed ID: 32842024 [TBL] [Abstract][Full Text] [Related]